Sona Nanotech Announces $2.0 Million Private Placement

Sona Nanotech (CSE: SONA) this morning announced that it is looking to raise funds via a private placement. The company intends to raise a total of $2.0 million via a non-brokered private placement.

The financing will see a total of 2.0 million units of the company sold at $1.00 a piece, with each unit containing one common share an one half of a common share purchase warrant. Each warrant contains an exercise price of $1.25 per share and is valid for a period of two years from the date of issue.

Funds raised from the financing are to be used to generate further clinical data for the firms rapid COVID-19 nasal antigen test, as well as to pursue a European self-certification CE Mark designation, and to pursue further development and clinical trial validation work for the firms saliva-based COVID-19 test. Funds are to also be used for general working capital.

Furthermore, the company also announced that it has appointed Obelis S.A as its authorized rep in the European Union to complete the CE Mark process for its diagnostic devices. As part of the process, the two firms will work together to compile the required technical information to acquire the CE designation, as well as with the firms contract manufacturer to complete the tech transfer required for its batch production runs.

Sona Nanotech last traded at $1.02 on the CSE.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver’s Finally Breaking the System | Keith Neumeyer – First Majestic

The Best News for Gold Was the Drop! – Peter Grandich

McEwen Copper: The Los Azules Feasibility Study

Recommended

Silver47 Completes Property-Wide Geochemical, Rock Sampling Program At Adams Plateau, Identifies Numerous Targets

Altamira Gold Identifies Presence Of Second Mineralized Porphyry Body At Cajueiro

Related News

‘CBD Supports the Immune System’ Austrian Clinic’s Cannabis Trial Suggests Encouraging Results for Covid-19 Patients

According to researchers at the Klagenfurt Clinic in Austria, CBD has shown promising results for...

Saturday, February 6, 2021, 05:14:00 PM

Households Amassed a Pile of Excess Cash in 2020. Will it Fuel the Economic Recovery?

The economic restrictions imposed during the height of the second world war make today’s pandemic-induced...

Saturday, March 13, 2021, 11:45:00 AM

Sona Nanotech: Health Canada Evaluation Results Did Not Match Prior Analytical And Clinical Study Data

Sona Nanotech (CSE: SONA) this morning elaborated on its decision to withdraw its antigen test...

Monday, November 30, 2020, 09:16:04 AM

Stocks, Oil, Crypto Sent Plummeting as New Covid-19 Variant Emerges

It appears that the Covid-19 pandemic is far from over. A new, significantly more aggressive...

Saturday, November 27, 2021, 10:57:00 AM

Feds Investigate $120,000 Jury Bribery Attempt in Major COVID-19 Relief Fraud Case

Federal authorities in Minnesota have confiscated cellphones and taken all seven defendants into custody as...

Wednesday, June 5, 2024, 11:40:00 AM